RxDoctor Payments DataLook up a doctor →

Richard Schilling, DPM

Podiatrist · Columbus, OHNPI 1245238849

Payments from drug & device makers

$47,819in general payments, 2019–2025

Across 311 payments — averaging $153.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Royal Biologics, Inc.$27K
  • Kerecis Limited$8K
  • Alfasigma USA, Inc.$3K
  • Triad Life Sciences Inc.$2K
  • Smith+Nephew$1K
  • Amgen$693
  • plus $5K from 42 others
$23,848in research payments, 2019–2025

Across 4 payments — averaging $5962.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kerecis Limited$24K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Royal Biologics, Inc.13$27,370
Kerecis Limited3$7,618
Alfasigma USA, Inc.8$3,409
Triad Life Sciences Inc.8$2,252
Smith+Nephew94$1,386
Amgen(2 entities)26$693
Paratek Pharmaceuticals, Inc.33$641
Treace Medical Concepts, Inc.2$619
Misonix Inc23$530
Nevro Corp.11$459
Stryker8$358
Paragon 28, Inc.8$229
Bioventus LLC7$210
Organogenesis Inc.6$199
Melinta Therapeutics, LLC9$177
Cardiovascular Systems Inc.2$169
ETS Wound Care LLC6$155
Flower Orthopedics Coporation1$150
Linvatec Corporation1$125
Baudax Bio Inc.1$100
GE HealthCare1$79
Inari Medical, Inc.3$74
Tenex Health Inc.1$61
Globus Medical2$59
Convatec Inc.2$57
Zimmer Biomet2$57
KCI USA, Inc.3$47
Metric Medical Devices, Inc.1$43
Vertex2$37
Celularity Inc.2$36
Reprise Biomedical, Inc.2$33
Johnson & Johnson1$33
Kowa Pharmaceuticals America, Inc.2$32
Novo Nordisk2$30
Access Pro Medical, LLC1$28
Trimed, Inc.1$27
Teva Pharmaceuticals USA, Inc.1$26
Biocomposites Inc1$25
Reapplix Inc.1$25
Medtronic1$22
Abbott1$21
Orthofix Medical, Inc.1$21
Trice Medical, Inc.2$21
Nabriva Therapeutics, PLC1$17
Integra Lifesciences Corporation1$17
Lilly USA, LLC1$16
Solventum Corporation1$14
Merck1$14

How this compares

$47,819 in reported general payments places this provider in the 95th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio →

Medicare billing

Part B allowed, 2024
$118,652
Medicare patients
273
Services billed
1,341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Columbus

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →